Hydrogen-rich saline prevents remifentanil-induced hyperalgesia and inhibits MnSOD nitration via regulation of NR2B-containing NMDA receptor in rats

Neuroscience

Volumn 280, Issue , 2014, Pages 171-180

  Zhang, L ^a,b   Shu, R ^a,b   Wang, H ^a,b   Yu, Y ^a,b   Wang, C ^a,b   Yang, M ^a,b   Wang, M ^a,b   Wang, G ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Institute of Tianjin Medicine   (China)

Author keywords

Hydrogen rich saline; Manganese superoxide dismutase; N methyl d aspartate; Opioid induced hyperalgesia; Ro25 6981

Indexed keywords

ANTINOCICEPTIVE AGENT; HYDROGEN RICH SALINE; MANGANESE SUPEROXIDE DISMUTASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; REMIFENTANIL; UNCLASSIFIED DRUG; 4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; AMINO ACID RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; HYDROGEN; NARCOTIC ANALGESIC AGENT; NR2A NMDA RECEPTOR; NR2B NMDA RECEPTOR; PHENOL DERIVATIVE; PIPERIDINE DERIVATIVE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; ENZYME REGULATION; HYPERALGESIA; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; MALE; NITRATION; NONHUMAN; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; DRUG EFFECTS; HEAT; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM; NOCICEPTION; PAIN, POSTOPERATIVE; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; TOUCH;

ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; ANIMALS; EXCITATORY AMINO ACID ANTAGONISTS; HOT TEMPERATURE; HYDROGEN; HYPERALGESIA; INJECTIONS, INTRAPERITONEAL; MALE; NOCICEPTION; PAIN, POSTOPERATIVE; PHENOLS; PIPERIDINES; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SODIUM CHLORIDE; SPINAL CORD DORSAL HORN; SUPEROXIDE DISMUTASE; TOUCH;

EID: 84907737784     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2014.09.024     Document Type: Article

References (36)

1. Ahmadi S., Muth-Selbach U., Lauterbach A., Lipfert P., Neuhuber W.L., Zeilhofer H.U. Facilitation of spinal NMDA receptor currents by spillover of synaptically released glycine. Science 2003, 27:2094-2097.
2. Angst M.S., Clark J.D. Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 2006, 104:570-587.
3. Bannister K., Sikandar S., Bauer C.S., Dolphin A.C., Porreca F., Dickenson A.H. Pregabalin suppresses spinal neuronal hyperexcitability and visceral hypersensitivity in the absence of peripheral pathophysiology. Anesthesiology 2011, 115:144-152.
4. Bornemann-Cimenti H., Lederer A.J., Wejbora M., Michaeli K., Kern-Pirsch C., Archan S. Preoperative pregabalin administration significantly reduces postoperative opioid consumption and mechanical hyperalgesia after transperitoneal nephrectomy. Br J Anaesth 2012, 108:845-849.
5. Brennan T.J., Vandermeulen E.P., Gebhart G.F. Characterization of a rat model of incisional pain. Pain 1996, 64(3):493-501.
6. Cabañero D., Campillo A., Célérier E., Romero A., Puig M.M. Pronociceptive effects of remifentanil in a mouse model of postsurgical pain: effect of a second surgery. Anesthesiology 2009, 111(6):1334-1345.
7. Celerier E., Gonzalez J.R., Maldonado R., Cabañero D. Opioid-induced hyperalgesia in a murine model of postoperative pain. Anesthesiology 2006, 104:546-555.
8. Chen Z.M., Muscoli C., Doyle T., Bryant L., Cuzzocrea S. NMDA receptor activation and nitroxidative regulation of the glutamatergic pathway during nociceptive processing. PAIN 2010, 149(1):100-106.
9. Chizh B.A. Low dose ketamine: a therapeutic and research tool to explore N-methyl-d-aspartate (NMDA) receptor-mediated plasticity in pain pathways. J Psychopharmacol 2007, 21:259-271.
10. Chu L.F., Angst M.S., Clark D. Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations. Clin J Pain 2008, 24:479-496.
11. Gao X., Kim H.K., Chung K., Chung J.M. Reactive oxygen species (ROS) are involved in enhancement of NMDA-receptor phosphorylation in animal models of pain. Pain 2007, 131:262-271.
12. Gu X., Wu X., Liu Y., Cui S., Ma Z. Tyrosine phosphorylation of the N-methyl-d-aspartate receptor 2B subunit in spinal cord contributes to remifentanil-induced postoperative hyperalgesia: the preventive effect of ketamine. Mol Pain 2009, 5:76.
13. Guntz E., Dumont H., Roussel C., Gall D., Dufrasne F., Cuvelier L., Blum D., Schiffmann S.N., Sosnowski M. Effects of remifentanil on N-methyl-d-aspartate receptor: an electrophysiologic study in rat spinal cord. Anesthesiology 2005, 102:1235-1241.
14. Gwak Y.S., Hassler S.E., Hulsebosch C.E. Reactive oxygen species contribute to neuropathic pain and locomotor dysfunction via activation of CamKII in remote segments following spinal cord contusion injury in rats. Pain 2013, 1699-1708.
15. Hong B.H., Lee W.Y., Kim Y.H., Yoon S.H., Lee W.H. Effects of intraoperative low dose ketamine on remifentanil induced hyperalgesia in gynecologic surgery with sevoflurane anesthesia. Korean J Anesthesiol 2011, 61(3):238-243.
16. Im Y.B., Jee M.K., Choi J.I., Cho H.T., Kwon O.H., Kang S.K. Molecular targeting of NOX4 for neuropathic pain after traumatic injury of the spinal cord. Cell Death Dis 2012, 3:e426.
17. Ishida R., Nikai T., Hashimoto T., Tsumori T., Saito Y. Intravenous infusion of remifentanil induces transient withdrawal hyperalgesia depending on administration duration in rats. Anesth Analg 2012, 114:224-229.
18. Jiang M., Zhang W., Ma Z.L., Gu X.P. Antinociception and prevention of hyperalgesia by intrathecal administration of Ro 25-6981, a highly selective antagonist of the 2B subunit of N-methyl-d-aspartate receptor. Pharmacol Biochem Behav 2013, 112:56-63.
19. Klaus H., Joke N., Hugo K., Buerkle H., Halene T., Schauerte S. Remifentanil directly activates human N-methyl-d-aspartate receptors expressed in Xenopus laevis oocytes. Anesthesiology 2004, 100:1531-1537.
20. Kostera-Pruszczyk A., Niebroj-Dobosz I., Emeryk-Szajewska B., Karwanska A., Rowinska-Marcinska K. Motor unit hyperexcitability in amyotrophic lateral sclerosis vs amino acids acting as neurotransmitters. Acta Neurol Scand 2002, 106:34-38.
21. Lee M., Silverman S.M., Hansen H., Patel V.B., Manchikanti L. A comprehensive review of opioid-induced hyperalgesia. Pain Physician 2011, 14:145-161.
22. Lenz H., Raeder J., Draeqni T., Hayerdahl F., Schmelz M., Stubhauq A. Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans. Pain 2011, 152(6):1289-1297.
23. Li J., Wang C., Cai J.M. Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress. Brain Res 2010, 1328:152-161.
24. Li Y., Wang H., Xie K., Wang C., Yang Z. Inhibition of glycogen synthase kinase-3β prevents remifentanil-induced hyperalgesia via regulating the expression and function of spinal N-methyl-d-aspartate receptors in vivo and vitro. PLoS ONE 2013, 8(10):e77790.
25. Liang D.Y., Li X., Clark J.D. 5-Hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice. Anesthesiology 2011, 114:1180-1189.
26. Mori H., Mishina M. Structure and function of the NMDA receptor channel. Neuropharmacology 1995, 34:1219-1237.
27. Ohnesorge H., Feng Z., Zitta K., Steinfath M., Albrecht M. Influence of clonidine and ketamine on m-RNA expression in a model of opioid-induced hyperalgesia in mice. PLoS ONE 2013, 8(11):e79567.
28. Storkson R.V., Kjorsvik A., Tjolsen A., Hole K. Lumbar catheterization of the spinal subarachnoid space in the rat. J Neurosci Methods 1996, 65:167-172.
29. von Engelhardt J., Coserea I., Pawlak V., Fuchs E.C., Seeburg P.H., Monyer H. Excitotoxicity in vitro by NR2A- and NR2B-containing NMDA receptors. Neuropharmacology 2007, 53:10-17.
30. Wang Z.Q., Porreca F., Cuzzocrea S. A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 2004, 309(3):869-878.
31. Yowtak J., Lee K.Y., Kim H.Y., Wang J.G., Kim H.K., Chung K., Chung J.M. Reactive oxygen species contribute to neuropathic pain by reducing spinal GABA release. Pain 2011, 844-852.
32. Yuan Y., Wang J.Y., Yuan F., Xie K.L., Yu Y.H., Wang G.L. Glycogen synthase kinase-3β contributes to remifentanil-induced postoperative hyperalgesia via regulating N-methyl-d-aspartate receptor trafficking. Anesth Analg 2013, 116(2):473-481.
33. Zhang L.L., Shu R.C., Wang H.Y., Wang C.Y., Li N., Wang G.L. Hydrogen-rich saline controls remifentanil-induced hypernociception and NMDA receptor NR1 subunit membrane trafficking through GSK-3β in the DRG in rats. Brain Res Bull 2014, 106:47-55.
34. Zhao M., Joo D.T. Enhancement of spinal N-methyl-d-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance. Anesthesiology 2008, 109(2):308-317.
35. Zheng Y., Cui S., Liu Y., Zhang J., Zhang W., Zhang J. Dexmedetomidine prevents remifentanil-induced postoperative hyperalgesia and decreases spinal tyrosine phosphorylation of N-methyl-d-aspartate receptor 2B subunit. Brain Res Bull 2012, 87(4-5):427-431.
36. Zhou L., Wang X., Xue W. Beneficial effects of hydrogen-rich saline against spinal cord ischemia-reperfusion injury in rabbits. Brain Res 2013, 23(1517):150-160.